Title:
NOVEL PHARMACEUTICAL COMPOSITIONS OF RANOLAZINE
Document Type and Number:
WIPO Patent Application WO/2010/137040
Kind Code:
A3
Abstract:
A novel controlled release pharmaceutical dosage form comprising a therapeutically effective amount of ranolazine or pharmaceutically acceptable salt(s), polymorph(s), solvate(s), hydrate(s), enantiomer(s) thereof, one or more lipid(s) as release controlling agent(s) and one or more pharmaceutically acceptable excipient(s).
More Like This:
Inventors:
BHASALE KETAN (IN)
NAIK RAGHAVENDRA (IN)
DAS SUBHASIS (IN)
THOMMANDRU VIJAYA KUMAR (IN)
NAIK RAGHAVENDRA (IN)
DAS SUBHASIS (IN)
THOMMANDRU VIJAYA KUMAR (IN)
Application Number:
PCT/IN2010/000356
Publication Date:
February 05, 2015
Filing Date:
May 26, 2010
Export Citation:
Assignee:
LUPIN LTD (IN)
BHASALE KETAN (IN)
NAIK RAGHAVENDRA (IN)
DAS SUBHASIS (IN)
THOMMANDRU VIJAYA KUMAR (IN)
BHASALE KETAN (IN)
NAIK RAGHAVENDRA (IN)
DAS SUBHASIS (IN)
THOMMANDRU VIJAYA KUMAR (IN)
International Classes:
A61K31/495; A61K9/00; A61P9/10
Foreign References:
| CN1891218A | 2007-01-10 |
Other References:
See also references of EP 2515880A4
Attorney, Agent or Firm:
MAJUMDAR, Subhatosh et al. (5 Harish Mukherjee Road, Kolkata 5, IN)
Download PDF:
Previous Patent: METHOD FOR PRODUCTION OF FERMENTABLE SUGARS FROM BIOMASS
Next Patent: MULTIPLE-KEY LOCK
Next Patent: MULTIPLE-KEY LOCK